Patent · US Active

Lipid vesicle compositions and methods of use

US9149432B2 · kind B2 · utility

14Cited by
12References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 19, 2012
Grant dateOct 6, 2015
Priority date
Expiry dateFeb 19, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides delivery systems comprised of stabilized multilamellar vesicles, as well as compositions, methods of synthesis, and methods of use thereof. The stabilized multilamellar vesicles comprise terminal-cysteine-bearing antigens or cysteine-modified antigens, at their surface and/or internally.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.